Communiqués de presse Archive - Page 13 of 19 - Ose Immunotherapeutics - Société de biotechnologie intégrée qui développe des immunothérapies innovantes

OSE Immunotherapeutics Announces First Peer-Reviewed Publication in Science Advances on OSE-230

OSE Immunotherapeutics Receives Authorization for Phase 1 Clinical Trial of CoVepiT

OSE Immunotherapeutics Reports 2020 Financial Results

OSE Immunotherapeutics and ARCAGY – GINECO Announce Initiation of a Randomized Phase 2 Clinical Trial

OSE Immunotherapeutics to Present New Data at AACR 2021

OSE Immunotherapeutics Presentation at H.C. Wainwright Global Life Sciences Conference

OSE Immunotherapeutics Announces Granting of First European Patent Protecting OSE-127

OSE Immunotherapeutics Enters a Loan Agreement of up to €25 Million with the European Investment Bank

OSE Immunotherapeutics Expands its Collaboration with MAbSilico

INCREASE IN RESOURCES DEVOTED TO THE LIQUIDITY CONTRACT OSE IMMUNOTHERAPEUTICS

Précédent
1
…
10
11
12
13
14
15
16
…
19
Suivant